The company provides project management consultancy and turnkey technology solutions for industrial projects, primarily in the pharmaceutical and agro-based sectors, and has recently expanded into drone technology and renewable energy infrastructure.
The company lacks a sustainable moat, as evidenced by extremely low average net margins of 1.2% and a ROCE of 1.9%, which are significantly below the cost of capital. The business operates as a fragmented service provider without identifiable switching costs, brand power, or scale advantages that translate into pricing power.
Capital allocation is poor, characterized by low-return investments in various unrelated entities and joint ventures like CKIM Pharma LLP, which reported zero turnover. The company frequently seeks shareholder approval for large inter-corporate loans and related-party transactions that have yet to yield meaningful ROIC.
The company's demise was driven by the aggressive diversion of capital into a web of related-party loans and non-performing joint ventures, which ultimately failed to generate any return. As the core business continued to earn less than its cost of capital, the already thin equity base was eroded by administrative overhead and interest costs. The lack of promoter skin-in-the-game led to a total breakdown in governance, where the remaining assets were hollowed out through inter-corporate deposits, leaving minority shareholders with a shell of a company that had no viable operations or cash flow.
RichFakir rates Vivanta Industries Ltd's business quality as poor — 3/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Vivanta Industries Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Vivanta Industries Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Vivanta Industries Ltd's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →